Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18052089rdf:typepubmed:Citationlld:pubmed
pubmed-article:18052089lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0040399lld:lifeskim
pubmed-article:18052089lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:18052089pubmed:issue26lld:pubmed
pubmed-article:18052089pubmed:dateCreated2007-12-20lld:pubmed
pubmed-article:18052089pubmed:abstractTextBoth enantiomers of 2-amino-2-methyl-4-iodo-3-(E)-butenoic acid (IVAIB, 5) were radioiodoinated in 65-72% yield. (S)-IVAIB entered 9L gliosarcoma cells primarily via A-type transport in vitro with higher uptake than (R)-IVAIB. Biodistribution studies in rats with 9L gliosarcoma brain tumors demonstrated higher tumor to brain ratios with (S)-IVAIB (75:1 at 1 h) than (R)-IVAIB (7.7:1). In this model, (S)-IVAIB is superior to (R)-IVAIB and is a promising radiotracer for brain tumor imaging.lld:pubmed
pubmed-article:18052089pubmed:languageenglld:pubmed
pubmed-article:18052089pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:citationSubsetIMlld:pubmed
pubmed-article:18052089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18052089pubmed:statusMEDLINElld:pubmed
pubmed-article:18052089pubmed:monthDeclld:pubmed
pubmed-article:18052089pubmed:issn0022-2623lld:pubmed
pubmed-article:18052089pubmed:authorpubmed-author:OlsonJeffreyJlld:pubmed
pubmed-article:18052089pubmed:authorpubmed-author:YuWeipingWlld:pubmed
pubmed-article:18052089pubmed:authorpubmed-author:GoodmanMark...lld:pubmed
pubmed-article:18052089pubmed:authorpubmed-author:McConathyJona...lld:pubmed
pubmed-article:18052089pubmed:authorpubmed-author:CampVernon...lld:pubmed
pubmed-article:18052089pubmed:issnTypePrintlld:pubmed
pubmed-article:18052089pubmed:day27lld:pubmed
pubmed-article:18052089pubmed:volume50lld:pubmed
pubmed-article:18052089pubmed:ownerNLMlld:pubmed
pubmed-article:18052089pubmed:authorsCompleteYlld:pubmed
pubmed-article:18052089pubmed:pagination6718-21lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:meshHeadingpubmed-meshheading:18052089...lld:pubmed
pubmed-article:18052089pubmed:year2007lld:pubmed
pubmed-article:18052089pubmed:articleTitleFacile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography.lld:pubmed
pubmed-article:18052089pubmed:affiliationmgoodma@emory.edu.lld:pubmed
pubmed-article:18052089pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18052089pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18052089pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18052089lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18052089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18052089lld:pubmed